Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD

Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment

Originalsprache	Englisch
ISSN	0009-7322
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.123.065330
Status	Veröffentlicht - 20.02.2024

PubMed	38377256